Project Grant K01HL176409
Award Date 7/1/26
Completion Date 6/30/31
Dollars Obligated $155K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Farmington, CT 06030, USA
Similar Awards
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the Regents of the University of California, San Francisco $752,904 on June 10, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support an implementation science initiative addressing HIV and hypertension care integration in sub-Saharan Africa. The project, titled "From Evidence to Scale: Implementation Science and Simulation Modeling to Transform HIV-Hypertension Care...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $782,085 Project Grant award dated June 25, 2026, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds research through February 28, 2031, to identify actionable multilevel intervention strategies designed to improve cardiovascular health outcomes among people with HIV (PWH). The project will employ...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $494,283 to the University of Botswana's Office of Research and Development on September 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and implement evidence-based strategies for integrating statin therapy into existing HIV service delivery in Botswana. Building on findings from the 2022 REPRIEVE study demonstrating that statins reduce cardiovascular risk among...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $798,698 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 10, 2025, with completion targeted for June 30, 2030. The project, titled "Cardiac Function and Proteomic Biomarkers in Individuals with Perinatal HIV Infection or Exposure," aims to comprehensively characterize cardiac dysfunction...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $1.42 million to Massachusetts General Hospital under the Cardiovascular Diseases Research program (CFDA 93.837) to establish and conduct the Uganda Lung Health Study, a longitudinal cohort research initiative examining the intersection of sex, HIV status, and chronic obstructive pulmonary disease (COPD) risk across the adult lifespan in sub-Saharan Africa. The award, issued September 15, 2025, with...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $763,858 Project Grant to Brigham & Women's Hospital on September 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). The project, titled "Optimizing Cardiovascular Care and Promoting Excellent Health Outcomes for Adults with Diabetes Across Settings," will develop and validate the PREDICT-DM Global Simulation Model to assess the clinical impact, cost-effectiveness,...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Pennsylvania a $692,846 Project Grant on September 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct the BETTER Heart Study (Behavioral Science Strategies to Increase Hypertension Diagnosis and Treatment). This four-year research initiative, concluding June 30, 2030, will deliver a randomized controlled trial with factorial design to evaluate two scalable...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Connecticut Health Center a $293,395 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective August 15, 2025, with a completion date of July 31, 2028. This award supports the "Democratizing Access to Cleaner Residential Air" (DACRA) initiative, which investigates the efficacy and feasibility of low-cost Corsi-Rosenthal boxes as an intervention to reduce...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Alabama at Birmingham $223,438 on September 4, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a clinical research study examining hypertension incidence in people with HIV initiating antiretroviral therapy (ART). The project, scheduled for completion by August 31, 2027, will assess blood pressure outcomes in ART-naïve individuals starting either...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Southern California a $14.74 million Project Grant on September 5, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop innovative in vivo cell engineering strategies for an HIV cure. The research program, structured as a multi-project initiative with three interacting projects (KIEM, CANNON, and SCADDEN), leverages recent advances in gene and cell therapy...